Katya Farkas' practice focuses on advising clients in the life sciences and medical devices sectors in relation to regulatory matters and public and administrative law litigation before the UK and EU Courts. Ms. Farkas has assisted with litigation before UK and EU courts arising from the decisions of regulatory bodies such as the Medicines and Healthcare products Regulatory Agency (MHRA) and the European Medicines Agency (EMA).

Ms. Farkas recently completed a secondment to a global pharmaceutical company where she worked on a broad range of commercial matters including pharmacovigilance regulations, GDPR, regulation of promotion and advertising and use of websites and social media in relation to medicinal products and medical devices. She has also assisted with work relating to public inquiries into medicinal products.

Prior to joining the firm, Ms. Farkas worked for a law firm in Los Angeles, California.


2022 EU/UK Life Sciences Future Forum Full Day Bootcamp
Arnold & Porter's Future Pharma Forum, London
Chambers Global Practice Guide: Life Sciences 2022 (pdf)
Chambers and Partners, UK
EU Clinical Trials Regulation: Today is the Day!
BioSlice Blog
The European Commission's New Pharmaceutical Strategy for Europe


  • LPC, University of Law, London, 2015
  • BA, Law (Jurisprudence), University of Oxford, 2012
  • England and Wales

Email Disclaimer